Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-02-21 Purchase | 2023-02-21 8:05 pm | Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer | 5,823 | $0.8415 | $4,900 | 979,891 (Indirect Direct) | View |
| 2023-02-13 Purchase | 2023-02-13 4:03 pm | Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer | 5,606 | $0.8742 | $4,901 | 974,068 (Indirect Direct) | View |
| 2023-02-06 Purchase | 2023-02-06 4:03 pm | Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer | 5,040 | $0.9723 | $4,900 | 968,462 (Indirect Direct) | View |
| 2023-01-30 Purchase | 2023-01-30 4:03 pm | Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer | 7,027 | $0.6974 | $4,901 | 963,422 (Indirect Direct) | View |
| 2023-01-23 Purchase | 2023-01-23 5:03 pm | Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer | 6,839 | $0.7166 | $4,901 | 956,395 (Indirect Direct) | View |
| 2023-01-17 Purchase | 2023-01-18 4:04 pm | Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer | 6,783 | $0.7364 | $4,995 | 949,556 (Indirect Direct) | View |
| 2022-12-16 Purchase | 2022-12-19 4:22 pm | Context Therapeutics Inc. | CNTX | Minai-Azary Jennifer Lynn Chief Financial Officer | 25,000 | $0.74 | $18,500 | 40,000 (Direct) | View |
| 2022-12-16 Purchase | 2022-12-19 4:11 pm | Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer | 20,000 | $0.7398 | $14,796 | 942,773 (Indirect Direct) | View |
| 2022-12-09 Purchase | 2022-12-12 4:15 pm | Context Therapeutics Inc. | CNTX | Levit Alex C. Chief Legal Officer, Corp. Sec | 6,000 | $0.8491 | $5,095 | 61,983 (Indirect Direct) | View |
| 2022-08-19 Purchase | 2022-08-22 4:04 pm | Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer | 13,000 | $1.8511 | $24,064 | 922,773 (Indirect Direct) | View |
| 2022-08-17 Purchase | 2022-08-17 5:23 pm | Context Therapeutics Inc. | CNTX | Minai-Azary Jennifer Lynn Chief Financial Officer | 15,000 | $1.8 | $27,000 | 15,000 (Direct) | View |
| 2022-08-16 Purchase | 2022-08-17 5:22 pm | Context Therapeutics Inc. | CNTX | Sahmoud Tarek Chief Medical Officer | 10,000 | $1.95 | $19,500 | 10,000 (Direct) | View |
| 2021-12-16 Purchase | 2021-12-20 4:02 pm | Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer | 13,000 | $3.2192 | $41,850 | 909,773 (Indirect Direct) | View |
| 2021-10-22 Purchase(A) | 2021-12-17 4:18 pm | Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer | 10,000 | $5 | $50,000 | 896,781 (Indirect Direct) | View |
| 2021-10-22 Purchase | 2021-10-25 5:30 pm | Context Therapeutics Inc. | CNTX | Levit Alex C. Chief Legal Officer, Corp. Sec | 3,000 | $5 | $15,000 | 3,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-21 Option Award | 2024-03-22 08:04 am | N/A 2034-03-20 | Context Therapeutics Inc. | CNTX | Minai-Azary Jennifer Lynn Chief Financial Officer | 160,115 | $0 | 160,115 (Direct) | View |
| 2024-03-21 Option Award | 2024-03-22 08:01 am | N/A 2034-03-20 | Context Therapeutics Inc. | CNTX | Levit Alex C. Chief Legal Officer, Corp. Sec | 153,515 | $0 | 153,515 (Direct) | View |
| 2024-03-21 Option Award | 2024-03-22 08:01 am | N/A 2034-03-20 | Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer | 291,402 | $0 | 291,402 (Direct) | View |
| 2023-05-31 Option Award | 2023-05-31 4:53 pm | N/A 2033-05-30 | Context Therapeutics Inc. | CNTX | Kantoff Philip W. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-05-31 Option Award | 2023-05-31 4:53 pm | N/A 2033-05-30 | Context Therapeutics Inc. | CNTX | West Linda Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-05-31 Option Award | 2023-05-31 4:53 pm | N/A 2033-05-30 | Context Therapeutics Inc. | CNTX | Stacey Jennifer Evans Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-05-31 Option Award | 2023-05-31 4:52 pm | N/A 2033-05-30 | Context Therapeutics Inc. | CNTX | BERMAN RICHARD J Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-14 5:04 pm | N/A 2033-02-12 | Context Therapeutics Inc. | CNTX | Levit Alex C. Chief Legal Officer, Corp. Sec | 151,505 | $0 | 151,505 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-14 5:04 pm | N/A 2033-02-12 | Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer | 287,544 | $0 | 287,544 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-14 5:04 pm | N/A 2033-02-12 | Context Therapeutics Inc. | CNTX | Minai-Azary Jennifer Lynn Chief Financial Officer | 158,001 | $0 | 158,001 (Direct) | View |
| 2022-08-12 Option Award | 2022-08-12 4:31 pm | N/A 2032-08-11 | Context Therapeutics Inc. | CNTX | Sahmoud Tarek Chief Medical Officer | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-03 4:10 pm | N/A 2032-06-01 | Context Therapeutics Inc. | CNTX | West Linda Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-03 4:10 pm | N/A 2032-06-01 | Context Therapeutics Inc. | CNTX | Kantoff Philip W. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-03 4:09 pm | N/A 2032-06-01 | Context Therapeutics Inc. | CNTX | BERMAN RICHARD J Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-03 4:09 pm | N/A 2032-06-01 | Context Therapeutics Inc. | CNTX | Stacey Jennifer Evans Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-02-25 Option Award | 2022-02-25 4:43 pm | N/A 2032-02-24 | Context Therapeutics Inc. | CNTX | Levit Alex C. Chief Legal Officer, Corp. Sec | 107,870 | $0 | 107,870 (Direct) | View |
| 2022-02-25 Option Award | 2022-02-25 4:42 pm | N/A 2032-02-24 | Context Therapeutics Inc. | CNTX | Minai-Azary Jennifer Lynn Chief Financial Officer | 112,470 | $0 | 112,470 (Direct) | View |
| 2022-02-25 Option Award | 2022-02-25 4:38 pm | N/A 2032-02-24 | Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer | 254,300 | $0 | 254,300 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 4:56 pm | N/A 2032-02-14 | Context Therapeutics Inc. | CNTX | Dick Evan G. Former Section 16 officer | 29,223 | $0 | 29,223 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 4:48 pm | N/A 2032-02-14 | Context Therapeutics Inc. | CNTX | Rencher William F. Former Section 16 officer | 8,000 | $0 | 8,000 (Direct) | View |
| 2021-10-22 Exercise(A) | 2021-12-17 4:18 pm | N/A N/A | Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer | 52,680 | $7.14 | 896,781 (Indirect) | View |
| 2021-10-22 Exercise(A) | 2021-12-17 4:18 pm | 2020-12-20 2030-12-20 | Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer | 52,680 | $0 | 896,781 (Indirect) | View |
| 2021-10-22 Conversion(A) | 2021-12-17 4:18 pm | N/A N/A | Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer | 797,190 | $0 | 896,781 (Indirect) | View |
| 2021-10-22 Conversion(A) | 2021-12-17 4:12 pm | N/A N/A | Context Therapeutics Inc. | CNTX | Dick Evan G. SVP of R&D | 26,587 | $0 | 82,960 (Direct) | View |
Ownership(A) | 2021-12-17 4:10 pm | N/A N/A | Context Therapeutics Inc. | CNTX | Dick Evan G. SVP of R&D | 0 | $0 | 56,373 (Direct) | View |
Ownership(A) | 2021-12-17 4:08 pm | N/A 2028-08-27 | Context Therapeutics Inc. | CNTX | Rencher William F. Head of CMC and Regulatory | 0 | $0 | 416 (Direct) | View |
| 2021-11-01 Option Award | 2021-11-01 4:31 pm | N/A 2031-11-01 | Context Therapeutics Inc. | CNTX | Minai-Azary Jennifer Lynn Chief Financial Officer | 52,753 | $0 | 52,753 (Direct) | View |